FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4368376847> ?p ?o ?g. }

• W4368376847 abstract "The impact of age on the efficacy and safety of immunotherapy remains controversial. The previous studies simply classified patients into younger and older groups, which might not reflect the real impact of young age on immunotherapy efficacy. The current study aimed to explore the efficacy and safety of immune checkpoint inhibitor (ICI) combined therapy in young (aged 18-44 years), middle-aged (aged 45-65 years), and old (aged >65 years) patients with metastatic gastrointestinal cancers (GICs), and further determine the role of immunotherapy in young patients.Patients with metastatic GIC including esophageal cancer (EC), gastric cancer (GC), hepatocellular cancer (HCC), and biliary tract cancer (BTC) who received ICI combination therapy were enrolled, divided into young (aged 18-44 years), middle-aged (aged 45-65 years), and old (aged >65 years) groups. The clinical characteristics, objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), overall survival (OS), and immune-related adverse events (irAEs) were compared among three groups.A total of 254 patients were finally included, with 18, 139, and 97 cases in the young (aged 18-44 years), middle-aged (aged 45-65 years), and old (aged >65 years) groups, respectively. Compared to middle-aged and old patients, young patients had lower DCR (all p < 0.05) and also had inferior PFS (p < 0.001) and OS (p = 0.017). The multivariate analyses showed that young age was an independent prognostic factor for PFS [hazard ratio (HR) 3.474, 95% confidence interval (CI) 1.962-6.150, p < 0.001] and OS (HR 2.740, 95% CI 1.348-5.570, p = 0.005). Subsequent safety analyses referring to irAEs demonstrated no significant differences for distribution frequency among each age group (all p > 0.05), whereas patients with irAEs displayed better DCR (p = 0.035) and PFS (p = 0.037).Younger GIC patients (aged 18-44 years) showed poor efficacy for ICI combined therapy, and irAEs could be used as a clinical biomarker to predict ICI efficacy in metastatic GIC patients." @default.
• W4368376847 created "2023-05-05" @default.
• W4368376847 creator A5014170190 @default.
• W4368376847 creator A5039252463 @default.
• W4368376847 creator A5045344252 @default.
• W4368376847 creator A5061545420 @default.
• W4368376847 creator A5070204057 @default.
• W4368376847 creator A5071146473 @default.
• W4368376847 creator A5073216396 @default.
• W4368376847 creator A5084923939 @default.
• W4368376847 date "2023-05-03" @default.
• W4368376847 modified "2023-10-14" @default.
• W4368376847 title "Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers" @default.
• W4368376847 cites W2127737941 @default.
• W4368376847 cites W2146844933 @default.
• W4368376847 cites W2488330279 @default.
• W4368376847 cites W2620869065 @default.
• W4368376847 cites W2770404972 @default.
• W4368376847 cites W2771261911 @default.
• W4368376847 cites W2775057452 @default.
• W4368376847 cites W2800356925 @default.
• W4368376847 cites W2806244319 @default.
• W4368376847 cites W2808441345 @default.
• W4368376847 cites W2883234341 @default.
• W4368376847 cites W2886819625 @default.
• W4368376847 cites W2912725678 @default.
• W4368376847 cites W2914997554 @default.
• W4368376847 cites W2922258220 @default.
• W4368376847 cites W2945928820 @default.
• W4368376847 cites W2950551738 @default.
• W4368376847 cites W2955628118 @default.
• W4368376847 cites W2958388343 @default.
• W4368376847 cites W2979129241 @default.
• W4368376847 cites W2982546811 @default.
• W4368376847 cites W3014650125 @default.
• W4368376847 cites W3014713533 @default.
• W4368376847 cites W3021590305 @default.
• W4368376847 cites W3025022288 @default.
• W4368376847 cites W3032115186 @default.
• W4368376847 cites W3036856678 @default.
• W4368376847 cites W3043347519 @default.
• W4368376847 cites W3047718208 @default.
• W4368376847 cites W3049212237 @default.
• W4368376847 cites W3087788702 @default.
• W4368376847 cites W3092162117 @default.
• W4368376847 cites W3112913477 @default.
• W4368376847 cites W3171517418 @default.
• W4368376847 cites W3203086530 @default.
• W4368376847 cites W4200279112 @default.
• W4368376847 doi "https://doi.org/10.3389/fonc.2023.1155019" @default.
• W4368376847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37207161" @default.
• W4368376847 hasPublicationYear "2023" @default.
• W4368376847 type Work @default.
• W4368376847 citedByCount "0" @default.
• W4368376847 crossrefType "journal-article" @default.
• W4368376847 hasAuthorship W4368376847A5014170190 @default.
• W4368376847 hasAuthorship W4368376847A5039252463 @default.
• W4368376847 hasAuthorship W4368376847A5045344252 @default.
• W4368376847 hasAuthorship W4368376847A5061545420 @default.
• W4368376847 hasAuthorship W4368376847A5070204057 @default.
• W4368376847 hasAuthorship W4368376847A5071146473 @default.
• W4368376847 hasAuthorship W4368376847A5073216396 @default.
• W4368376847 hasAuthorship W4368376847A5084923939 @default.
• W4368376847 hasBestOaLocation W43683768471 @default.
• W4368376847 hasConcept C121608353 @default.
• W4368376847 hasConcept C126322002 @default.
• W4368376847 hasConcept C143998085 @default.
• W4368376847 hasConcept C197934379 @default.
• W4368376847 hasConcept C205545832 @default.
• W4368376847 hasConcept C207103383 @default.
• W4368376847 hasConcept C2777701055 @default.
• W4368376847 hasConcept C44249647 @default.
• W4368376847 hasConcept C526805850 @default.
• W4368376847 hasConcept C542804219 @default.
• W4368376847 hasConcept C71924100 @default.
• W4368376847 hasConcept C90924648 @default.
• W4368376847 hasConceptScore W4368376847C121608353 @default.
• W4368376847 hasConceptScore W4368376847C126322002 @default.
• W4368376847 hasConceptScore W4368376847C143998085 @default.
• W4368376847 hasConceptScore W4368376847C197934379 @default.
• W4368376847 hasConceptScore W4368376847C205545832 @default.
• W4368376847 hasConceptScore W4368376847C207103383 @default.
• W4368376847 hasConceptScore W4368376847C2777701055 @default.
• W4368376847 hasConceptScore W4368376847C44249647 @default.
• W4368376847 hasConceptScore W4368376847C526805850 @default.
• W4368376847 hasConceptScore W4368376847C542804219 @default.
• W4368376847 hasConceptScore W4368376847C71924100 @default.
• W4368376847 hasConceptScore W4368376847C90924648 @default.
• W4368376847 hasLocation W43683768471 @default.
• W4368376847 hasLocation W43683768472 @default.
• W4368376847 hasOpenAccess W4368376847 @default.
• W4368376847 hasPrimaryLocation W43683768471 @default.
• W4368376847 hasRelatedWork W1900595920 @default.
• W4368376847 hasRelatedWork W1996388792 @default.
• W4368376847 hasRelatedWork W2114624491 @default.
• W4368376847 hasRelatedWork W2194631636 @default.
• W4368376847 hasRelatedWork W2343768426 @default.
• W4368376847 hasRelatedWork W2561875242 @default.
• W4368376847 hasRelatedWork W2767919106 @default.
• W4368376847 hasRelatedWork W3111094672 @default.

• next